CD177 and Bartsocas-Papas syndrome 1: In the low-risk group, BPs were predominantly involved in immune-related responses and pathways, encompassing cell activation involved in the immune response, immune response-regulating signalling pathways, activation of the immune response, leukocyte-mediated immunity, and immune response-regulating cell surface receptor signalling pathways.